Correlation Between Moleculin Biotech and Verona Pharma
Can any of the company-specific risk be diversified away by investing in both Moleculin Biotech and Verona Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moleculin Biotech and Verona Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moleculin Biotech and Verona Pharma PLC, you can compare the effects of market volatilities on Moleculin Biotech and Verona Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moleculin Biotech with a short position of Verona Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moleculin Biotech and Verona Pharma.
Diversification Opportunities for Moleculin Biotech and Verona Pharma
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Moleculin and Verona is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Moleculin Biotech and Verona Pharma PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verona Pharma PLC and Moleculin Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moleculin Biotech are associated (or correlated) with Verona Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verona Pharma PLC has no effect on the direction of Moleculin Biotech i.e., Moleculin Biotech and Verona Pharma go up and down completely randomly.
Pair Corralation between Moleculin Biotech and Verona Pharma
Given the investment horizon of 90 days Moleculin Biotech is expected to under-perform the Verona Pharma. In addition to that, Moleculin Biotech is 1.51 times more volatile than Verona Pharma PLC. It trades about -0.04 of its total potential returns per unit of risk. Verona Pharma PLC is currently generating about 0.26 per unit of volatility. If you would invest 1,196 in Verona Pharma PLC on August 31, 2024 and sell it today you would earn a total of 2,767 from holding Verona Pharma PLC or generate 231.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Moleculin Biotech vs. Verona Pharma PLC
Performance |
| Timeline |
| Moleculin Biotech |
| Verona Pharma PLC |
Moleculin Biotech and Verona Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Moleculin Biotech and Verona Pharma
The main advantage of trading using opposite Moleculin Biotech and Verona Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moleculin Biotech position performs unexpectedly, Verona Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verona Pharma will offset losses from the drop in Verona Pharma's long position.| Moleculin Biotech vs. Pulmatrix | Moleculin Biotech vs. Cyclacel Pharmaceuticals | Moleculin Biotech vs. Akari Therapeutics PLC | Moleculin Biotech vs. Bio Path Holdings |
| Verona Pharma vs. Cue Biopharma | Verona Pharma vs. Eliem Therapeutics | Verona Pharma vs. Inhibrx | Verona Pharma vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |